684
Views
14
CrossRef citations to date
0
Altmetric
Letters to the Editor

The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvement

, , , , , , & show all
Pages 2020-2023 | Received 15 Jan 2020, Accepted 28 Feb 2020, Published online: 19 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Khaled Sanber, Kevin Ye, Hua-Ling Tsai, Matthew Newman, Jonathan A. Webster, Ivana Gojo, Gabriel Ghiaur, Gabrielle T. Prince, Lukasz P. Gondek, B. Douglas Smith, Mark J. Levis, Amy E. DeZern, Alexander J. Ambinder, William B. Dalton & Tania Jain. (2023) Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease. Leukemia & Lymphoma 64:4, pages 846-855.
Read now

Articles from other publishers (11)

Soyoung Bae, Seungwon Sa, Silvia Park, Byung-Sik Cho & Hee-Je Kim. (2023) Limited Efficacy of Venetoclax Combination Regimens in Acute Myeloid Leukemia with Extramedullary Relapse. Acta Haematologica, pages 1-8.
Crossref
Leihua Fu, Zhijian Zhang, Zhe Chen, Jiaping Fu, Pan Hong & Weiying Feng. (2023) Gene Mutations and Targeted Therapies of Myeloid Sarcoma. Current Treatment Options in Oncology 24:4, pages 338-352.
Crossref
Kristin E. Zorn, Ashley M. Cunningham, Alison E. Meyer, Karen Sue Carlson & Sridhar Rao. (2023) Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology. Cancers 15:5, pages 1443.
Crossref
Shristi Upadhyay Banskota, Nabin Khanal, Rosalyn I. Marar, Prajwal Dhakal & Vijaya Raj Bhatt. (2022) Precision Medicine in Myeloid Malignancies: Hype or Hope?. Current Hematologic Malignancy Reports 17:6, pages 217-227.
Crossref
Denise Maravalle, Alessandra Filosa, Catia Bigazzi, Guido Collina & Piero Galieni. (2022) Long‐term remission of extramedullary cutaneous relapse of acute myeloid leukaemia (leukaemia cutis) treated with decitabine‐venetoclax. eJHaem 3:2, pages 517-520.
Crossref
Dina Rochate, Carolina Pavão, Rui Amaral, Carolina Viveiros, José Cabeçadas, Vitor Carneiro & Cristina Fraga. (2022) Extramedullary Acute Leukemia—Still an Unforeseen Presentation. Hematology Reports 14:2, pages 143-148.
Crossref
Aleksina Shatilova, Larisa Girshova, Daniil Zaytsev, Irina Budaeva, Yuliya Mirolyubova, Darya Ryzhkova, Roman Grozov, Konstantin Bogdanov, Tatiana Nikulina, Dmitriy Motorin, Darina Zammoeva, Svetlana Efremova, Vladimir Ivanov, Alexey Petukhov, Yuliya Alekseeva & Andrey Zaritskey. (2021) The myeloid sarcoma treated by Venetoclax with hypomethylating agent followed by stem cell transplantation: rare case report. BMC Women's Health 21:1.
Crossref
Brunangelo Falini, Sofia Sciabolacci, Lorenza Falini, Lorenzo Brunetti & Maria Paola Martelli. (2021) Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field. Leukemia 35:11, pages 3113-3126.
Crossref
Aleksina Alekseevna Shatilova, L.L. Girshova, D.V. Zaitsev, I.G. Budaeva, Yu.V. Mirolyubova, D.V. Ryzhkova, R.V. Grozov, K.V. Bogdanov, T.S. Nikulina, D.V. Motorin, D.B. Zammoeva, S.V. Efremova, V.V. Ivanov, A.V. Petukhov, Yu.A. Alekseeva & A.Yu. Zaritskey. (2021) Gynecological Myeloid Sarcoma: Literature Review and a Case Report. Clinical oncohematology 14:1, pages 31-44.
Crossref
Shyam A. Patel, Jacob R. Bledsoe, Jeffrey Gordon & Jan Cerny. (2021) Extramedullary Acute Myeloid Leukemia of the Renal Pelvis: Insights into a Visceral Niche. Acta Haematologica 144:3, pages 297-301.
Crossref
. (2020) Azacitidine/decitabine/venetoclax. Reactions Weekly 1822:1, pages 63-63.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.